Upcoming events

A picture of the San Francisco waterfront, where the ATS international conference will take place May 13-18, 2022.
Envisia Genomic Classifier and Percepta Genomic Sequencing Classifier Logos
May 13th–18th 2022 | San Francisco, CA
Come visit us at booth 1908 to learn more about Veracyte’s genomic diagnostic tests for interstitial lung disease and lung cancer.
Updated 2022 ILD Diagnosis & Treatment Guidelines

Get the Latest Guidance and Updates Including the Role of Envisia Genomic Classifier

ATS 2022 | Industry Theater

Integrating the Percepta Genomic Sequencing Classifier for Lung Nodule Risk Stratification

ATS 2022 | Industry Theater

Integrating Novel Genomic Data to Improve ILD Diagnostic and Prognostic Confidence

ATS 2022 Poster Presentation | Percepta Nasal Swab

A Nasal Genomic Classifier for Assessing Risk of Malignancy in Lung Nodules Demonstrates Similar Performance in Patients that Meet Screening ...

Start a conversation

Contact us for more information or if you have any questions about Veracyte’s suite of genomic tests for lung disease.